These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9552430)

  • 1. Drug solubility effects on predicting optimum conditions for extrusion and spheronization of pellets.
    Hileman GA; Upadrashta SM; Neau SH
    Pharm Dev Technol; 1997 Feb; 2(1):43-52. PubMed ID: 9552430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption.
    Iosio T; Voinovich D; Grassi M; Pinto JF; Perissutti B; Zacchigna M; Quintavalle U; Serdoz F
    Eur J Pharm Biopharm; 2008 Jun; 69(2):686-97. PubMed ID: 18191390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations on the influence of the type of extruder for pelletization by extrusion-spheronization. II. Sphere characteristics.
    Thoma K; Ziegler I
    Drug Dev Ind Pharm; 1998 May; 24(5):413-22. PubMed ID: 9876603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the extrusion die on pellet characteristics.
    Rabisková M; Weingartová D; Häring A
    Ceska Slov Farm; 2007 Jan; 56(1):17-20. PubMed ID: 17432277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    J Microencapsul; 2003; 20(5):613-25. PubMed ID: 12909545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of drug solubility on release behavior of calcium polysaccharide gel-coated pellets.
    Sriamornsak P; Kennedy RA
    Eur J Pharm Sci; 2007 Nov; 32(3):231-9. PubMed ID: 17889515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of water content and drug solubility on the formulation of pellets by extrusion and spheronisation.
    Lustig-Gustafsson C; Kaur Johal H; Podczeck F; Newton JM
    Eur J Pharm Sci; 1999 May; 8(2):147-52. PubMed ID: 10210738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of spherical pellets by a hot-melt extrusion and spheronization process.
    Young CR; Koleng JJ; McGinity JW
    Int J Pharm; 2002 Aug; 242(1-2):87-92. PubMed ID: 12176229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the formulation and process of Da Chuan Xiong Fang pellet by extrusion-spheronization].
    Hong YL; Feng Y; Xu DS; Jiang LH; Yang Y
    Zhong Yao Cai; 2007 Dec; 30(12):1596-600. PubMed ID: 18422197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the drying technique on theophylline pellets prepared by extrusion-spheronization.
    Pérez J; Rabisková M
    Int J Pharm; 2002 Aug; 242(1-2):349-51. PubMed ID: 12176277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Starch-dextrin mixtures as base excipients for extrusion-spheronization pellets.
    Almeida Prieto S; Blanco Méndez J; Otero Espinar FJ
    Eur J Pharm Biopharm; 2005 Apr; 59(3):511-21. PubMed ID: 15760732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
    Verheyen P; Steffens KJ; Kleinebudde P
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of omeprazole pellets fabricated by sieving-spheronization and extrusion - spheronization process.
    Karim S; Baie SH; Hay YK; Bukhari NI
    Pak J Pharm Sci; 2014 May; 27(3):425-38. PubMed ID: 24811797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; Remon JP; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations on the influence of the type of extruder for pelletization by extrusion-spheronization. I. Extrusion behavior of formulations.
    Thoma K; Ziegler I
    Drug Dev Ind Pharm; 1998 May; 24(5):401-11. PubMed ID: 9876602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Masking of unpleasant gustatory sensation by cross-linking of dehydrated paracetamol alginate pellets produced by extrusion-spheronization.
    Kulkarni RB; Amin PD
    Drug Dev Ind Pharm; 2008 Feb; 34(2):199-205. PubMed ID: 18302039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torque rheological parameters to predict pellet quality in extrusion-spheronization.
    Soh JL; Liew CV; Heng PW
    Int J Pharm; 2006 Jun; 315(1-2):99-109. PubMed ID: 16574352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.